No significant association was found between any of the ageing biomarkers and tumor size (pT)[29], nodal status (pN), histologic breast carcinoma subtype (ductal, lobular, combined or other) or molecular tumor subtype (luminal A, luminal B/Her2-, luminal B/Her2+, non-luminal Her2+, triple-negative) (data not shown). The gene discussed is ERBB2; the disease is neoplasm.